You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atovaquone, proguanil drug combination

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

Pneumonia, Pneumocystis Carinii, HIV Trial in Tanzania, United States (Atovaquone, Dapsone)

Completed
  • Pneumonia, Pneumocystis Carinii
  • HIV Infections
  • Birmingham, Alabama
  • +43 more
Oct 27, 2021

A Combination Drug Including Fimasartan and Statins in

Completed
  • Hypertension and Dyslipidemia
  • Combination drug containing fimasartan and statins
  • Gwangju, Jebong-ro, Jangseong-eup, Jangseong-gun, Korea, Republic of
    Chonnam National University Hospital
Nov 15, 2022

Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Noblesville, Indiana
    Investigative Clinical Research of Indiana
Oct 18, 2023

Arteriovenous Fistula Stenosis Trial in Singapore (Angioplasty)

Completed
  • Arteriovenous Fistula Stenosis
  • Angioplasty
  • Singapore, Singapore
    Singapore General Hospital
Jul 17, 2023

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

FDC, Diabetes, Type 2 Trial in Cheongju-si (DWC202213, DWJ1563, DWP16001)

Recruiting
  • FDC
  • Diabetes Mellitus, Type 2
  • Cheongju-si, Seowon-gu, Korea, Republic of
    Chungbuk National University Hospital
Feb 10, 2023

Suicide Crisis Syndrome, Psychological Distress Trial in New York (Clonazepam, Olanzapine, Buprenorphine)

Not yet recruiting
  • Suicide Crisis Syndrome
  • Psychological Distress
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 10, 2023

Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)

Not yet recruiting
  • Follicular Lymphoma
  • Axicabtagene Ciloleucel
  • +5 more
  • (no location specified)
Sep 21, 2023

Melanoma Trial in United States (IO102/IO103, Nivolumab-Relatlimab)

Recruiting
  • Melanoma
  • Basking Ridge, New Jersey
  • +6 more
Jun 23, 2023

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Gram Negative Pneumonia, Gram-Negative Bacterial Infections, Bacteremia Caused by Gram-Negative Bacteria Trial

Not yet recruiting
  • Gram Negative Pneumonia
  • +2 more
  • Fluorothiazinone, tablets 300 mg at a dose of 2400 mg/day
  • Placebo
  • (no location specified)
Nov 14, 2023

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

Active, not recruiting
Has Results
  • Waldenstrom's Macroglobulinemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Lenvatinib in Combination With Pembrolizumab in Korean Patients

Recruiting
  • Endometrial Neoplasms
  • +2 more
  • Non-interventional
  • Ilsan, Gyeongji-do, Korea, Republic of
  • +14 more
Nov 21, 2022

Lung Cancer Trial in Houston (NKTR-255, Durvalumab)

Not yet recruiting
  • Lung Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 30, 2022

Advanced Solid Tumor Trial (CVL218)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 9, 2023

Multiple Myeloma Trial in Charlotte (Elotuzumab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 24, 2023

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Malaria Trial (Ganaplacide, Lumefantrine, Efavirenz)

Completed
  • Malaria
  • Belfast, Northern Ireland, United Kingdom
    Novartis Investigative Site
Jan 11, 2023

Chronic Lymphocytic Leukemia, Richter Syndrome Trial in United States (Duvelisib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Richter Syndrome
  • Miami, Florida
  • +6 more
Jan 6, 2023